Axogen, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Axogen, Inc. (AXGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 2.26% for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2022-11-08
- Axogen, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2022-03-31 was 2.15%, a 88.60% increase year-over-year.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2021-03-31 was 1.14%, a 100.00% increase year-over-year.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2020-03-31 was 0.57%, a 77.99% decline year-over-year.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2019-03-31 was 2.59%, a 8.37% increase year-over-year.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2020 was 0.49%, a 71.35% decline from fiscal 2019.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2019 was 1.71%, a 36.67% decline from fiscal 2018.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2018 was 2.70%, a 27.36% increase from fiscal 2017.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2017 was 2.12%, a 23.26% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | 2.26% 10-Q · filed 2022-11-08 | ||||
| 2022-06-30 | 2.22% 10-Q · filed 2022-08-05 | ||||
| 2022-03-31 | 2.15% 10-Q · filed 2022-05-05 | ||||
| 2021-09-30 | 1.01% 10-Q · filed 2021-11-04 | ||||
| 2021-06-30 | 1.03% 10-Q · filed 2021-08-05 | ||||
| 2021-03-31 | 1.14% 10-Q · filed 2021-05-06 | ||||
| 2020-12-31 | 0.49% 10-K · filed 2021-03-01 | ||||
| 2020-09-30 | 0.35% 10-Q · filed 2020-10-30 | ||||
| 2020-06-30 | 0.38% 10-Q · filed 2020-08-07 | ||||
| 2020-03-31 | 0.57% 10-Q · filed 2020-05-06 | ||||
| 2019-12-31 | 1.71% 10-K · filed 2021-03-01 | ||||
| 2019-09-30 | 1.54% 10-Q · filed 2020-10-30 | ||||
| 2019-06-30 | 2.59% 10-Q · filed 2020-08-07 | 1.87% 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | 2.59% 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | 2.70% 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | 2.69% 10-Q · filed 2019-11-06 | ||||
| 2018-06-30 | 2.55% 10-Q · filed 2019-08-06 | ||||
| 2018-03-31 | 2.39% 10-Q · filed 2019-05-08 | ||||
| 2017-12-31 | 2.12% 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | 2.07% 10-Q · filed 2018-10-29 | ||||
| 2017-06-30 | 2.08% 10-Q · filed 2018-08-01 | ||||
| 2017-03-31 | 2.14% 10-Q · filed 2018-04-30 | ||||
| 2016-12-31 | 1.72% 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | 1.22% 10-Q · filed 2017-11-01 | ||||
| 2016-06-30 | 1.23% 10-Q · filed 2017-08-02 | ||||
| 2016-03-31 | 1.24% 10-Q · filed 2017-05-04 | ||||
| 2015-12-31 | 1.40% 10-K · filed 2018-02-28 | ||||
| 2015-09-30 | 1.27% 10-Q · filed 2016-11-02 | ||||
| 2015-06-30 | 1.21% 10-Q · filed 2016-08-03 | ||||
| 2015-03-31 | 1.28% 10-Q · filed 2016-05-04 | ||||
| 2014-12-31 | 1.26% 10-K · filed 2016-02-29 | ||||
| 2014-09-30 | 1.23% 10-Q · filed 2015-11-05 | ||||
| 2014-06-30 | 1.20% 10-Q · filed 2015-08-06 | ||||
| 2014-03-31 | 1.12% 10-Q · filed 2015-05-05 | ||||
| 2013-12-31 | 0.79% 10-K · filed 2015-03-05 | ||||
| 2013-09-30 | 0.71% 10-Q · filed 2014-11-13 | ||||
| 2013-06-30 | 0.60% 10-Q · filed 2014-08-04 | ||||
| 2013-03-31 | 0.56% 10-Q · filed 2014-04-30 | ||||
| 2012-12-31 | 0.61% 10-K · filed 2014-03-06 | ||||
| 2012-09-30 | 0.60% 10-Q · filed 2013-10-30 | ||||
| 2012-06-30 | 0.63% 10-Q · filed 2013-08-14 | ||||
| 2012-03-31 | 0.62% 10-Q · filed 2013-04-30 | ||||
| 2011-12-31 | 1.27% 10-K/A · filed 2013-08-07 | ||||
| 2011-09-30 | 1.43% 10-Q · filed 2012-11-06 | ||||
| 2011-06-30 | 1.49% 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |